Reporter Nov 21 2014
-
New tools to probe manganese biology
Vanderbilt researchers have developed tools to probe the role of the essential metal manganese in neurons, and which offer a started point for developing therapeutic agents for manganese-related neurological disorders. Read MoreNov 26, 2014
-
Protein implicated in atherosclerosis
Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease. Read MoreNov 25, 2014
-
Gene influences allergies in asthma
A particular gene is associated with a specific type of inflammatory response in people with asthma – a finding that could suggest new therapeutic targets for treating asthma. Read MoreNov 24, 2014
-
Host sequesters zinc to control stomach bug
Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk. Read MoreNov 21, 2014
-
Reunion helps build, reinforce alumni connections
Rainy weather couldn’t dampen the festivities as nearly 1,200 medical and nursing alumni returned to campus for Reunion for Vanderbilt University School of Medicine (VUSM) and Vanderbilt University School of Nursing (VUSN) Read MoreNov 20, 2014
-
Gene mutation linked to breast cancer therapy resistance
A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. Read MoreNov 20, 2014
-
Team finds drug repurposing signal in e-health records
With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden therapeutic benefits that could warrant putting additional indications on the label and increasing production. Read MoreNov 20, 2014
-
Tindle to direct Tobacco Research and Treatment
November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer. Read MoreNov 20, 2014
-
New protocol for young brain injury patients shows success
A new protocol put into place more than a year ago at Monroe Carrell Jr. Children’s Hospital at Vanderbilt is showing early signs of improving outcomes for patients with traumatic brain injuries. Read MoreNov 20, 2014
-
Study finds national decline in one type of serious heart attack
The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments’ quality and timeliness of care. Read MoreNov 20, 2014
-
Down Syndrome group honors McMillan
Elise McMillan, J.D., received the Mollie Burd Gavigan Service Award from the Down Syndrome Association of Middle Tennessee (DSAMT) in recognition of McMillan’s “instrumental role in improving the lives of individuals with Down syndrome in Middle Tennessee.” The award was presented recently at the annual DSAMT Buddy Race. Read MoreNov 20, 2014
-
Young girl’s road to recovery paved at Children’s Hospital
When Kendra Kaufman walked into to a recent follow-up appointment with surgeon Dai Chung, M.D., the only help she needed to steady her steps came from ankle-foot-orthotics. Read MoreNov 20, 2014
-
Rodgers honored for service to VUSM, students
Hundreds of students gathered this week at a reception honoring Scott Rodgers, M.D., and his 10 years of service to Vanderbilt University School of Medicine. Read MoreNov 20, 2014
-
ECMO program celebrates 25 years of saving lives
For 25 years, patients at Monroe Carell Jr. Children’s Hospital at Vanderbilt, like 20-month-old Easton Cunningham, have been given a second chance at life when their lungs or heart, or sometimes both, have failed to perform. Read MoreNov 20, 2014
-
Receptor discovery shines new light on appetite regulation
A receptor in the brain that regulates appetite and body weight has now been found in L cells, key regulatory cells in the gut, providing the pharmaceutical industry with a novel drug target for both obesity and diabetes, a Vanderbilt University-led research team reported this week. Read MoreNov 20, 2014